St. John's Wort (Hypericum perforatum): A plurivalent raw material for modern and traditional therapies;Johanniskraut (Hypericum perforatum): Ein plurivalenter rohstoff für traditionelle und moderne therapien

Forschende Komplementarmedizin und Klassische Naturheilkunde

Volumn 10, Issue SUPPL. 1, 2003, Pages 33-40

  Saller, Reinhard ^a,c   Melzer, J ^a   Reichling, J ^b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c Stadtspital Triemli Departement fur Innere Medizin Abteilung fur Gastroenterologie   (Switzerland)

Author keywords

Antidepressant effects; Hypericum perforatum; Multicompound; St. John's wort

Indexed keywords

HYPERICUM PERFORATUM EXTRACT;

ALTERNATIVE MEDICINE; APOPTOSIS; ASIA; CLINICAL TRIAL; CONFERENCE PAPER; CONVALESCENCE; DEPRESSION; EUROPE; EXHAUSTION; GASTROINTESTINAL DISEASE; HERBAL MEDICINE; HUMAN; HYPERICUM PERFORATUM; NERVOUSNESS; NORTH AFRICA; NURSING; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RESTLESSNESS; SKIN DISEASE; SLEEP DISORDER; SOMATOFORM DISORDER;

ANTIOXIDANTS; DEPRESSION; HUMANS; HYPERICUM; PHYTOTHERAPY; PLANT EXTRACTS; SKIN DISEASES; TREATMENT OUTCOME;

EID: 0038203515     PISSN: 14247364     EISSN: None     Source Type: Journal    
DOI: 10.1159/000071690     Document Type: Conference Paper

References (67)

1. Albert D, Zundorf I, Dingermann T, Muller WE, Steinhilber D, Werz O: Hyperforin is a dual inhibitor of cyclooxygenase-1 and 5-lipoxygenase. Biochem Pharmacol 2002;64:1767-1775.
2. Barnes J, Anderson LA, Phillipson JD: St John's wort (Hypericum perforatum L.): a review of its chemistry, pharmacology and clinical properties. J Pharm Pharmacol 2001;53:583-600.
3. Bilia AR, Gallori S, Vincieri FF: St. John's wort and depression: efficacy, safety and tolerability - an update. Life Sci 2002;70:3077-3096.
4. Butterweck V, Jurgenliemk G, Nahrstedt A, Winterhoff H: Flavonoids from Hypericum perforatum show antidepressant activity in the forced swimming test. Planta Med 2000;66:3-6.
5. Butterweck V, Nahrstedt A, Evans J, Hufeisen S, Rauser L, Savage J, Popadak B, Ernsberger P, Roth BL: In vitro receptor screening of pure constituents of St. John's wort reveals novel interactions with a number of GPCRs. Psychopharmacology (Berl) 2002:162;193-202.
6. Chen B, Roskams T, Xu Y, Agostinis P, de Witte PA: Photodynamic therapy with hypericin induces vascular damage and apoptosis in the RIF-1 mouse tumor model. Int J Cancer 2002;98:284-290.
7. Couladis M, Badisa RB, Baziou P, Chaudhuri SK, Pilarinou E, Verykokidou E, Harvala C: Antioxidant and cytotoxic activities of Hypericum sp. on brine shrimps and human cancer cell lines. Phytother Res 2002;16:719-722.
8. Delinini-Stula A, Lorenz J, Holsboer-Trachsler E: Pflanzliche Antidepressiva. Schweiz Med Forum 2002;48:1146-1154.
9. De Smet PA: Herbal remedies. N Engl J Med 2002;347:2046-2056.
10. Flausino OA Jr, Zangrossi H Jr, Salgado JV, Viana MB: Effects of acute and chronic treatment with Hypericum perforatum L. (LI 160) on different anxiety-related responses in rats. Pharmacol Biochem Behav 2002;71:251-257.
11. Gorman JM, Sloan RP: Heart rate variability in depressive and anxiety disorders. Am Heart J 2000;140(suppl 4):77-83.
12. Helgason CM, Frank JL, Johnson DR, Frank MG, Hendricks SE: The effects of St. John's wort (Hypericum perforatum) on NK cell activity in vitro. Immunopharmacology 2000;46:247-251.
13. Henderson L, Yue QY, Bergquist C, Gerden B, Arlett P: St John's wort (Hypericum perforatum): Drug interactions and clinical outcomes. Br J Clin Pharmacol 2002:54;349-356.
14. Hesslinger B, Harter M, Barth J, Klecha D, Bode C, Walden J, Bengel J, Berger M: Komorbidität von depressiven Störungen und kardiovaskulären Erkrankungen. Implikationen für Diagnostik, Pharmako- und Psychotherapie. Nervenarzt 2002:73;205-217.
15. Hostanska K, Reichling J, Bommer S, Weber M, Saller R: Aqueous ethanolic extract of St. John's wort (Hypericum perforatum L.) induces growth inhibition and apoptosis in human malignant cells in vitro. Pharmazie 2002;57:323-331.
16. Hübner WD, Kirste T: Experience with St John's Wort (Hypericum perforatum) in children under 12 years with symptoms of depression and psychovegetative disturbances. Phytother Res 2001:15;367-370.
17. Hunt EJ, Lester CE, Lester EA, Tackett RL: Effect of St. John's wort on free radical production. Life Sci 2001;69:181-190.
18. Iten F, Reichling J, Saller R: Unerwünschte Wirkungen und Wechselwirkungen von Phytotherapeutika. Ther Umsch 2002;59:283-291.
19. Ivetic V, Popovic M, Mimica-Dukic N, Barak O, Pilija V: St. John's wort (Hypericum perforatum L.) and kindling epilepsy in rabbit. Phytomedicine 2002;9:496-499.
20. Jang MH, Lee TH, Shin MC, Bahn GH, Kim JW, Shin DH, Kim EH, Kim CJ: Protective effect of Hypericum perforatum Linn (St. John's wort) against hydrogen peroxide-induced apoptosis on human neuroblastoma cells. Neurosci Lett 2002;329:177-180.
21. Kalbermatten R: Wesen und Signatur der Heilpflanzen. Die Gestalt als Schlüssel der Heilkraft der Pflanzen. Aarau, AT, 2002.
22. Kasper S, Dienel A: Cluster analysis of symptoms during antidepressant treatment with Hypericum extract in mildly to moderately depressed out-patients. A meta-analysis of data from three randomized, placebo-controlled trials. Psychopharmacology (Berl) 2002;164:301-308.
23. Kenner D, Requena Y: Botanical Medicine: A European Professional Perspective. Brookline, MT, Paradigm, 1996.
24. Khalifa AE:Hypericum perforatum as a nootropic drug: enhancement of retrieval memory of a passive avoidance conditioning paradigm in mice. J Ethnopharmacol 2001;76:49-57.
25. Kumar V, Singh PN, Bhattacharya SK: Anti-inflammatory and analgesic activity of Indian Hypericum perforatumL. Indian J Exp Biol 2001;39:339-343.
26. Kumar V, Singh PN, Bhattacharya SK: Anti-stress activity of Indian Hypericum perforatum L. Indian J Exp Biol 2001;39:344-349.
27. Lavagna SM, Secci D, Chimenti P, Bonsignore L, Ottaviani A, Bizzarri B: Efficacy of Hypericum and Calendula oils in the epithelial reconstruction of surgical wounds in childbirth with caesarean section. Farmaco 2001;56:451-453.
28. Lenoir S, Degenring FH, Saller R: A double-blind randomised trial to investigate three different concentrations of a standardised fresh plant extract obtained from the shoot tips of Hypericum perforatum L. Phytomedicine 1999;6:141-146.
29. Linde K, ter Riet G, Hondras M, Vickers A, Saller R, Melchart D: Systematic reviews of complementary therapies - an annotated bibliography. Part 2: Herbal medicine. BMC Complement Altern Med 2001;1:5.
30. Madaus G: Lehrbuch der biologischen Heilmittel. (Nachdruck der Ausgabe Leipzig 1938) Hildesheim, Olms, 1979.
31. Makina DM, Taranukhin AG, Chernigovskaya EV, Kuzik VV: Effect of Hypericum extract on the hypothalamic-pituitary-adrenal system in rats. Bull Exp Biol Med 2001;132:1180-1181.
32. Masand PS: Weight gain associated with psychotropic drugs. Expert Opin Pharmacother 2000:1;377-389.
33. Mathijssen RH, Verweij J, de Bruijn P, Loos WJ, Sparreboom A: Effects of St. John's wort on irinotecan metabolism. J Natl Cancer Inst 2002;94:1247-1249.
34. Meier B: Comparing phytopharmaceuticals: The example of St. John's Wort. Adv Ther 2001;18:35-46.
35. Mowrey DB: Herbal tonic therapies. New Canaan, Keats,1993.
36. Mueller BM: Effects of hypericum extract HYP 811 in patients with psychovegetative disorders. Adv Ther 1998;15:255-260.
37. Nakatani N: Phenolic antioxidants from herbs and spices. Biofactors 2000;13:141-146.
38. Noldner M, Schotz K: Rutin is essential for the antidepressant activity of Hypericum perforatum extracts in the forced swimming test. Planta Med 2002;68:577-580.
39. Pfister R: Japanese herbal medicine. The healing art of Kampo. Garden City Park New York, Avery, 2000.
40. Ploberger F: Westliche Kräuter aus Sicht der Traditionellen Chinesischen Medizin. Linz, Bacopa (ohne Jahreszahl).
41. Raso GM, Pacilio M, Di Carlo G, Esposito E, Pinto L, Meli R: In-vivo and in-vitro anti-inflammatory effect of Echinacea purpurea and Hypericum perforatum. J Pharm Pharmacol 2002;54:1379-1383.
42. Reichling J, Weseler A, Saller R: A current review of the antimicrobial activity of Hypericum perforatum L. Pharmacopsychiatry 2001;34(suppl 1):S116-S118.
43. Reichling J, Hostanska K, Saller R: Johanniskraut (Hypericum perforatum L.) - Vielstoffgemische kontra phytogene Einzelstoffe. Forsch Komplementärmed Klass Naturheilkd 2003:10(suppl 1):28-32.
44. Rugulies R: Depression as a predictor for coronary heart disease. A review and meta-analysis. Am J Prev Med 2002:23;51-61.
45. Saller R, Reichling J, Hellenbrecht D: Phytotherapie. Klinische, pharmakologische und pharmazeutische Grundlagen. Heidelberg, Haug, 1995.
46. Schempp CM, Kirkin V, Simon-Haarhaus B, Kersten A, Kiss J, Termeer CC, Gilb B, Kaufmann T, Borner C, Sleeman JP, Simon JC: Inhibition of tumour cell growth by hyperforin, a novel anticancer drug from St. John's wort that acts by induction of apoptosis. Oncogene 2002;21:1242-1250.
47. Schempp CM, Muller KA, Winghofer B, Schopf E, Simon JC: Johanniskraut (Hypericum perforatum L.). Eine Pflanze mit Relevanz für die Dermatologie. Hautarzt 2002;53:316-321.
48. Schempp CM, Simon-Haarhaus B, Simon JC: Phototoxic and apoptosis-inducing capacity of pseudohypericin. Planta Med 2002;68:171-173.
49. Schempp CM, Winghofer B, Ludtke R, Simon-Haarhaus B, Schopf E, Simon JC: Topical application of St John's wort (Hypericum perforatum L.) and of its metabolite hyperforin inhibits the allostimulatory capacity of epidermal cells. Br J Dermatol 2000;142:979-984.
50. Schulz V: Clinical trials with hypericum extracts in patients with depression - results, comparisons, conclusions for therapy with antidepressant drugs. Phytomedicine 2002;9:468-474.
51. Schulz V: Hypericum perforatum; in Blaschek W, Ebel S, Hackenthal E, Holzgrabe U, Keller K, Reichling J (Hrsg): Hagers Handbuch der Drogen und Arzneistoffe. Hager ROM 2002, Springer electronic media.www.Hagerrom.de
52. Siepmann M, Krause S, Joraschky P, Muck-Weymann M, Kirch W: The effects of St John's wort extract on heart rate variability, cognitive function and quantitative EEG: A comparison with amitriptyline and placebo in healthy men. Br J Clin Pharmacol 2002;54:277-282.
53. Spinella M: The importance of pharmacological synergy in psychoactive herbal medicines. Altern Med Rev 2002;7:130-137.
54. Stein PK, Carney RM, Freedland KE, Skala JA, Jaffe AS, Kleiger RE, Rottman JN: Severe depression is associated with markedly reduced heart rate variability in patients with stable coronary heart disease. J Psychosom Res 2000;48:493-500.
55. Timoshanko A, Stough C, Vitetta L, Nathan PJ: A preliminary investigation on the acute pharmacodynamic effects of hypericum on cognitive and psychomotor performance. Behav Pharmacol 2001;12:635-640.
56. Tobler M, Schneider E: Naturgerechte Standardisierung von Phytopharmaka, Beispiel: Frischpflanzenpräparate. Z Phytother 2001;22:10-21.
57. Tripathi YB, Pandey E: Role of alcoholic extract of shoot of Hypericum perforatum Linn on lipid peroxidation and various species of free radicals in rats. Indian J Exp Biol 1999;37:567-571.
58. Tschupp CP: Hypericum perforatum L. Vom Hexenkraut zum modernen Arzneimittel. Inaugural-dissertation (Pharmazie), Universität Bern, 1989.
59. Vandenbogaerde A, Zanoli P, Puia G, Truzzi C, Kamuhabwa A, De Witte P, Merlevede W, Baraldi M: Evidence that total extract of Hypericum perforatum affects exploratory behavior and exerts anxiolytic effects in rats. Pharmacol Biochem Behav 2000;65:627-633.
60. Verotta L: Hypericum perforatum, a source of neuroactive lead structures. Curr Top Med Chem 2003;3:187-201.
61. Volz HP, Murck H, Kasper S, Moller HJ: St John's wort extract (LI 160) in somatoform disorders: Results of a placebo-controlled trial. Psychopharmacology (Berl) 2002;164:294-300.
62. Vorbach EU, Arnoldt KH, Wolpert E: St John's wort: a potential therapy for elderly depressed patients? Drugs Aging 2000;16:189-197.
63. Whiskey E, Werneke U, Taylor D: A systematic review and meta-analysis of Hypericum perforatum in depression: A comprehensive clinical review. Int Clin Psychopharmacol 2001;16:239-252.
64. WHO: HerbaHyperici; in World Health Organization WHO Monographs on Selected Medicinal Plants. vol 2. Geneva, WHO, 2002.
65. Wilhelm KP, Biel S, Siegers CP: Role of flavonoids in controlling the phototoxicity of Hypericum perforatum extracts. Phytomedicine 2001;8:306-309.
66. Williamson EM: Synergy and other interactions in phytomedicines. Phytomedicine 2001;8:401-409.
67. Zheng W, Wang SY: Antioxidant activity and phenolic compounds in selected herbs. J Agric Food Chem 2001;49:5165-5170.